🟢 Surgepays is trading 7.2% up in pre-market with no verified company-specific catalyst

Surgepays is trading at $0.16, up 7.17% in pre-market on October 28, 2026, with no verified company-specific announcement explaining the move.

• GrowthLine launch was reported October 15, not overnight.
• October 27 results showed a broad tech-led market rally, while Wednesday’s index signals are mixed. This backdrop may offer general support, but available evidence does not establish it as the direct cause. The prior session’s gain and recent sharp fluctuations indicate elevated activity.